LINK TO ONE OF OUR 57 MEMBER ASSOCIATIONS FOR LOCAL SUPPORT, ADVICE AND NEWS

view map
close
  • Finland
  • Norway
  • Sweden
  • Estonia
  • Russian Federation
  • Latvia
  • Denmark
  • Lithuania
  • United Kingdom
  • Netherlands
  • Ireland
  • Poland
  • Germany
  • Belgium
  • Czech Republic
  • Ukraine
  • Slovakia
  • Luxembourg
  • Moldova, Republic of
  • Austria
  • France
  • Switzerland
  • Romania
  • Slovenia
  • Croatia
  • Serbia
  • Bosnia & Herzegovina
  • Bulgaria
  • Italy
  • Macedonia, the Former Yugoslav Republic of
  • Spain
  • Greece
  • Israel

AVAILABLE TO WATCH NOW: AAV-Based Gene Therapy and Prevail Therapeutic's Approach For Neuronopathic Gaucher Diseases & Parkinson's Disease with a GBA Mutation

15 October 2020

The second in a series of educational webinars for our members on the latest developments in gene therapy focused on AAV-based gene therapy and Prevail Therapeutic's approach for neuronopathic Gaucher disease and Parkinson’s disease with a GBA mutation.

Our speakers from Prevail Therapeutics were Dr Eriene Wasef (Medical Director) and Dr Olga Uspenskaya-Cadoz (Vice President, Clinical Development) at Prevail.

WATCH IT NOW

For more details about Prevail's gene therapy please visit: https://www.prevailtherapeutics.com/programs/